A detailed history of Bernzott Capital Advisors transactions in Enovis Corp stock. As of the latest transaction made, Bernzott Capital Advisors holds 14,920 shares of ENOV stock, worth $696,913. This represents 0.39% of its overall portfolio holdings.

Number of Shares
14,920
Previous 61,615 75.79%
Holding current value
$696,913
Previous $3.45 Million 73.02%
% of portfolio
0.39%
Previous 1.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$55.44 - $63.8 $2.59 Million - $2.98 Million
-46,695 Reduced 75.79%
14,920 $931,000
Q4 2023

Feb 12, 2024

SELL
$43.67 - $57.07 $493,034 - $644,320
-11,290 Reduced 15.49%
61,615 $3.45 Million
Q3 2023

Oct 23, 2023

BUY
$51.65 - $65.54 $472,339 - $599,363
9,145 Added 14.34%
72,905 $3.84 Million
Q2 2023

Jul 27, 2023

BUY
$52.7 - $64.12 $3.36 Million - $4.09 Million
63,760 New
63,760 $4.09 Million

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.53B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Bernzott Capital Advisors Portfolio

Follow Bernzott Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bernzott Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bernzott Capital Advisors with notifications on news.